ReviewMolecules (Basel, Switzerland)2025
Recent Applications of Albumin as a Green and Versatile Catalyst in Organic Synthesis.
Review in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Today, biocatalytic methodologies are well established as useful tools in green organic synthesis, since biocatalysts are mild, sustainable, and environmentally friendly catalysts which provide selectivity to the reactions they catalyse. Albumin, the most abundant protein of mammalian blood, is a versatile and mild biocatalyst in vitro. The aim of this review is to provide a perspective on the synthetic applications of albumin over the last decade. These cover transformations with a diverse chemical basis, such as additions, eliminations, and oxidations, including formation of carbon-carbon and carbon-heteroatom bonds. Albumin can also be applied in tandem and multicomponent reactions and offers a mild alternative for the synthesis of different heterocyclic cores. In addition to its synthetic possibilities, the remarkable reusability of this protein offers interesting potential from a biotechnological point of view.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.